Citation: | LI Wanchao, CAI Songtao, YAN Ming, LU Yiting, DENG Zhiling, LU Panpan, LI Haixin, XU Zhijie. Cross-cultural adaptation, reliability and validity of GP-pharmacist collaboration assessment questionnaire[J]. Chinese Journal of General Practice, 2024, 22(6): 1013-1017. doi: 10.16766/j.cnki.issn.1674-4152.003556 |
[1] |
KWAK M J, CHENG M, GOYAL P, et al. Medication complexity among older adults with HF: how can we assess better?[J]. Drugs Aging, 2022, 39(11): 851-861. doi: 10.1007/s40266-022-00979-2
|
[2] |
TURK A, WONG G, MAHTANI K R, et al. Optimising a person-centred approach to stopping medicines in older people with multimorbidity and polypharmacy using the DExTruS framework: a realist review[J]. BMC Med, 2022, 20(1): 297. doi: 10.1186/s12916-022-02475-1
|
[3] |
张亚琳, 廖晓阳, 赵茜, 等. 基层整合型医疗服务的国际经验和中国实践[J]. 中华全科医学, 2021, 19(6): 887-891. doi: 10.16766/j.cnki.issn.1674-4152.001942
ZHANG Y L, LIAO X Y, ZHAO Q, et al. International experience and practice of integrated primary care in China[J]. Chinese Journal of General Practice, 2021, 19(6): 887-891. doi: 10.16766/j.cnki.issn.1674-4152.001942
|
[4] |
NI X F, YANG C S, BAI Y M, et al. Drug-related problems of patients in primary health care institutions: a systematic review[J]. Front Pharmacol, 2021, 12: 698907. DOI: 10.3389/fphar.2021.698907.
|
[5] |
韩悦, 杨振华, 韩庆烽, 等. 多病共存患者认知功能的管理现状[J]. 中华全科医学, 2023, 21(8): 1388-1392. doi: 10.16766/j.cnki.issn.1674-4152.003129
HAN Y, YANG Z H, HAN Q F, et al. Current status of management of cognitive function in patients with multimorbidity[J]. Chinese Journal of General Practice, 2023, 21(8): 1388-1392. doi: 10.16766/j.cnki.issn.1674-4152.003129
|
[6] |
邓志玲, 陆益婷, 梁旭健, 等. 基层药师与全科医生团队合作的研究进展、挑战及应对策略[J]. 中国全科医学, 2023, 26(10): 1179-1185. doi: 10.12114/j.issn.1007-9572.2022.0615
DENG Z L, LU Y T, LIANG X J, et al. Collaboration between Primary Care Pharmacists and General Practitioner Teams: Recent Developments, Challenges and Countermeasures[J]. Chinese General Practice, 2023, 26(10): 1179-1185. doi: 10.12114/j.issn.1007-9572.2022.0615
|
[7] |
HASAN IBRAHIM A S, BARRY H E, HUGHES C M. GPs' and pharmacists' views of integrating pharmacists into general practices: a qualitative study[J]. Br J Gen Pract, 2023, 73(731): e407-e417. doi: 10.3399/BJGP.2022.0518
|
[8] |
TRENAMAN S C, KENNIE-KAULBACH N, D' ENTREMONT-MACVICAR E, et al. Implementation of pharmacist-led deprescribing in collaborative primary care settings[J]. Int J Clin Pharm, 2022, 44(5): 1216-1221. doi: 10.1007/s11096-022-01449-w
|
[9] |
RAHAYU S A, WIDIANTO S, DEFI I R, et al. Role of pharmacists in the interprofessional care team for patients with chronic diseases[J]. J Multidiscip Healthc, 2021, 14: 1701-1710. doi: 10.2147/JMDH.S309938
|
[10] |
CLAIRE M, CLAIRE A, MATTHEW B. The role of clinical pharmacists in general practice in England: impact, perspectives, barriers and facilitators[J]. Res Social Adm Pharm, 2022, 18(8): 3432-3437. doi: 10.1016/j.sapharm.2021.10.006
|
[11] |
KARAMPATAKIS G D, PATEL N, STRETCH G, et al. Integration and impact of pharmacists in general practice internationally: a rapid review[J]. J Health Serv Res Policy, 2024, 29(1): 56-67. doi: 10.1177/13558196231179831
|
[12] |
ALSHEHRI A A, CHEEMA E, YAHYOUCHE A, et al. Evaluating the role and integration of general practice pharmacists in England: a cross-sectional study[J]. Int J Clin Pharm, 2021, 43(6): 1609-1618. doi: 10.1007/s11096-021-01291-6
|
[13] |
CAI S T, HUANG X H, VAN C, et al. General practitioners' attitudes towards and frequency of collaboration with pharmacists in China: a cross-sectional study[J]. BMC Health Serv Res, 2023, 23(1): 1174. doi: 10.1186/s12913-023-10151-0
|
[14] |
SUDESHIKA T, DEEKS L S, NAUNTON M, et al. Interprofessional collaboration within general practice teams following the inclusion of non-dispensing pharmacists[J]. J Pharm Policy Pract, 2023, 16(1): 49. doi: 10.1186/s40545-023-00550-3
|
[15] |
WEISSENBORN M, KRASS I, VAN C, et al. Process of translation and cross-cultural adaptation of two Australian instruments to evaluate the physician-pharmacist collaboration in Germany[J]. Res Social Adm Pharm, 2020, 16(1): 74-83. doi: 10.1016/j.sapharm.2019.03.009
|
[16] |
BEATON D E, BOMBARDIER C, GUILLEMIN F, et al. Guidelines for the process of cross-cultural adaptation of self-report measures[J]. Spine (Phila Pa 1976), 2000, 25(24): 3186-3191. doi: 10.1097/00007632-200012150-00014
|
[17] |
YAO M, XU B P, TIAN Z R, et al. Cross-cultural adaptation of the neck pain and disability scale: a methodological systematic review[J]. Spine J, 2019, 19(6): 1057-1066. doi: 10.1016/j.spinee.2019.01.007
|
[18] |
黄雪梅, 徐晓媛, 杨帅, 等. 国外医师与药师协作关系测量工具介绍及对我国的启示[J]. 中国药事, 2020, 34(10): 1200-1208. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGYS202010012.htm
HUANG X M, XU X Y, YANG S, et al. A Review of Instruments for physician-Pharmacist Collaboration Abroad and Its Enlightenment to China[J]. Chinese Pharmaceutical Affairs, 2020, 34(10): 1200-1208. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGYS202010012.htm
|
[19] |
GRAEFF M D S, ALMEIDA M A, PORCEL-GÁLVEZ A M, et al. Cross-cultural adaptation and validation of instrument to measure nursing care dependency[J]. Rev Gaucha Enferm, 2022, 43: e20210135. DOI: 10.1590/1983-1447.2022.20210135.en.
|